TrialUrologic oncology

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer.

Seth P Lerner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.